Position
Squarepoint Ops LLC in Mirum Pharmaceuticals, Inc.
Back to the book · All holders of MIRM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $826.1K$78.99 → $92.38
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 172.4K | $13.6M | — | — | — | 0.0% |
| Q1 2026 | 61.7K | $5.7M | $92.38 | $826.1K | −$8.75M | 0.0% |